Zentalis Market Capitalization vs Invested Capital Analysis
ZNTL Stock | USD 12.54 0.17 1.34% |
Zentalis PharmaceuticalsL financial indicator trend analysis is more than just analyzing Zentalis PharmaceuticalsL current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Zentalis PharmaceuticalsL is a good investment. Please check the relationship between Zentalis PharmaceuticalsL Market Cap and its Invested Capital accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zentalis PharmaceuticalsLlc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
Market Cap vs Invested Capital
Market Capitalization vs Invested Capital Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Zentalis PharmaceuticalsL Market Capitalization account and Invested Capital. At this time, the significance of the direction appears to have strong relationship.
The correlation between Zentalis PharmaceuticalsL's Market Capitalization and Invested Capital is 0.78. Overlapping area represents the amount of variation of Market Capitalization that can explain the historical movement of Invested Capital in the same time period over historical financial statements of Zentalis PharmaceuticalsLlc, assuming nothing else is changed. The correlation between historical values of Zentalis PharmaceuticalsL's Market Capitalization and Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Market Capitalization of Zentalis PharmaceuticalsLlc are associated (or correlated) with its Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Invested Capital has no effect on the direction of Market Capitalization i.e., Zentalis PharmaceuticalsL's Market Capitalization and Invested Capital go up and down completely randomly.
Correlation Coefficient | 0.78 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Market Cap
Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to Zentalis PharmaceuticalsLlc. There are two different methods for calculating Zentalis PharmaceuticalsL invested capital: operating approach and financing approach. Understanding Zentalis PharmaceuticalsL invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Most indicators from Zentalis PharmaceuticalsL's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Zentalis PharmaceuticalsL current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zentalis PharmaceuticalsLlc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. Tax Provision is expected to rise to about (784.7 K) this year. The value of Selling General Administrative is expected to slide to about 38 M
2010 | 2019 | 2023 | 2024 (projected) | Interest Income | 355K | 498K | 572.7K | 469.2K | Net Interest Income | 355K | 498K | 572.7K | 469.2K |
Zentalis PharmaceuticalsL fundamental ratios Correlations
Click cells to compare fundamentals
Zentalis PharmaceuticalsL Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Zentalis PharmaceuticalsL fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 102.7M | 365.6M | 454.5M | 539.3M | 562.0M | 378.6M | |
Other Current Liab | 9.8M | 19.0M | 30.9M | 45.4M | 51.5M | 29.2M | |
Total Current Liabilities | 14.9M | 28.6M | 43.9M | 56.6M | 69.4M | 40.3M | |
Total Stockholder Equity | 76.8M | 333.4M | 364.5M | 434.0M | 437.3M | 306.3M | |
Other Liab | 4.2M | 2.5M | 1.6M | 3.5M | 3.1M | 2.3M | |
Net Tangible Assets | (92.6M) | 296.0M | 360.2M | 433.8M | 498.9M | 523.8M | |
Property Plant And Equipment Net | 2.8M | 3.6M | 52.8M | 50.1M | 41.7M | 27.8M | |
Net Debt | (81.6M) | (53.0M) | (13.8M) | 2.1M | 17.7M | 18.6M | |
Retained Earnings | (83.0M) | (200.8M) | (359.6M) | (596.4M) | (888.6M) | (844.1M) | |
Accounts Payable | 4.3M | 8.7M | 11.6M | 11.2M | 14.9M | 9.9M | |
Cash | 82.4M | 55.0M | 59.7M | 43.1M | 28.0M | 39.1M | |
Non Current Assets Total | 18.6M | 20.5M | 103.7M | 87.4M | 65.3M | 56.8M | |
Non Currrent Assets Other | 2.2M | 2.3M | 2.6M | (1.8M) | 6.8M | 7.2M | |
Other Assets | 0.0 | 4.3M | 9.7M | 12.4M | 14.2M | 14.9M | |
Cash And Short Term Investments | 82.4M | 338.5M | 339.9M | 437.4M | 482.9M | 312.8M | |
Net Receivables | 140K | 417K | 4.4M | 7.0M | 8.1M | 8.5M | |
Common Stock Total Equity | 25K | 41K | 45K | 59K | 53.1K | 50.4K | |
Common Stock Shares Outstanding | 35.9M | 41.0M | 42.7M | 52.9M | 65.4M | 46.9M | |
Liabilities And Stockholders Equity | 102.7M | 365.6M | 454.5M | 539.3M | 562.0M | 378.6M | |
Non Current Liabilities Total | 4.2M | 3.6M | 46.1M | 48.6M | 55.3M | 29.4M | |
Capital Lease Obligations | 781K | 2.0M | 45.9M | 45.2M | 43.2M | 25.1M | |
Other Current Assets | 1.5M | 6.2M | 10.9M | 14.6M | 13.8M | 8.7M | |
Other Stockholder Equity | 159.7M | 534.1M | 724.1M | 1.0B | 1.3B | 691.8M | |
Total Liab | 19.1M | 32.2M | 90.0M | 105.3M | 124.6M | 69.6M | |
Net Invested Capital | 76.8M | 308.6M | 364.0M | 433.8M | 437.3M | 290.6M | |
Property Plant And Equipment Gross | 2.8M | 3.6M | 53.6M | 7.7M | 44.9M | 47.1M | |
Total Current Assets | 84.1M | 345.1M | 350.8M | 451.9M | 496.7M | 321.8M | |
Accumulated Other Comprehensive Income | (141.7M) | 36K | (125K) | (1.4M) | 2.2M | 2.3M | |
Capital Stock | 25K | 41K | 45K | 59K | 70K | 66.5K | |
Net Working Capital | 69.2M | 316.5M | 306.8M | 395.3M | 427.4M | 281.5M | |
Common Stock | 25K | 41K | 45K | 59K | 70K | 66.5K | |
Property Plant Equipment | 2.8M | 3.6M | 8.1M | 7.7M | 8.9M | 5.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Zentalis PharmaceuticalsL is a strong investment it is important to analyze Zentalis PharmaceuticalsL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zentalis PharmaceuticalsL's future performance. For an informed investment choice regarding Zentalis Stock, refer to the following important reports:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zentalis PharmaceuticalsLlc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Zentalis Stock analysis
When running Zentalis PharmaceuticalsL's price analysis, check to measure Zentalis PharmaceuticalsL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zentalis PharmaceuticalsL is operating at the current time. Most of Zentalis PharmaceuticalsL's value examination focuses on studying past and present price action to predict the probability of Zentalis PharmaceuticalsL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zentalis PharmaceuticalsL's price. Additionally, you may evaluate how the addition of Zentalis PharmaceuticalsL to your portfolios can decrease your overall portfolio volatility.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Zentalis PharmaceuticalsL's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis PharmaceuticalsL. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis PharmaceuticalsL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.47) | Return On Assets (0.29) | Return On Equity (0.67) |
The market value of Zentalis PharmaceuticalsL is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis PharmaceuticalsL's value that differs from its market value or its book value, called intrinsic value, which is Zentalis PharmaceuticalsL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis PharmaceuticalsL's market value can be influenced by many factors that don't directly affect Zentalis PharmaceuticalsL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis PharmaceuticalsL's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zentalis PharmaceuticalsL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis PharmaceuticalsL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.